Disaggregation of Revenues, Geographic Sales and Product Sales

12 Months Ended

Dec. 30, 2022

Segment Reporting [Abstract]

Disaggregation of Revenues, Geographic Sales and Product Sales

Note 17 — Disaggregation of Revenues, Geographic Sales and Product Sales

In the following tables, revenues are disaggregated by category, sales by geographic market and sales by product data.  The following breaks down revenues into the following categories (in thousands):  

	Years Ended
	2022		2021		2020
Non-consignment sales	$	264,620	$	210,517	$	137,369
Consignment sales		19,771		19,955		26,091
Total net sales	$	284,391	$	230,472	$	163,460

The Company markets and sells its products in more than 75 countries and conducts its manufacturing in the United States. Other than China and Japan, the Company does not conduct business in any country in which its sales in that country exceed 10% of consolidated net sales. Sales are attributed to countries based on location of customers. The composition of the Company’s net sales to unaffiliated customers was as follows (in thousands):

	Years Ended
	2022		2021		2020
Domestic	$	14,679	$	10,095	$	6,158
Foreign:
China(1)		148,167		107,333		71,692
Japan		43,093		40,973		34,986
Other(2)		78,452		72,071		50,624
Total foreign sales		269,712		220,377		157,302
Total net sales	$	284,391	$	230,472	$	163,460

⁽¹⁾ The China region includes sales into China and Hong Kong.  

⁽²⁾ No other location individually exceeds 10% of the total net sales.

100% of the Company’s sales are generated from the ophthalmic surgical product segment and the chief operating decision maker makes the operating decisions and allocates resources based upon the consolidated operating results, therefore, the Company operates as one operating segment for financial reporting purposes. The Company’s principal products are IOLs used in cataract surgery and ICLs used in refractive surgery.  The composition of the Company’s net sales by product line was as follows (in thousands):

	Years Ended
	2022		2021		2020
ICLs	$	269,712	$	212,905	$	141,407
Other product sales
Cataract IOLs		9,638		12,519		13,574
Other surgical products(1)		5,041		5,048		8,479
Total other product sales		14,679		17,567		22,053
Total net sales	$	284,391	$	230,472	$	163,460

⁽¹⁾ Other surgical products include delivery systems and normal recurring sales adjustments such as sales return allowances.

The Company sells its products internationally, which subjects the Company to several potential risks, including fluctuating exchange rates (to the extent the Company’s transactions are not in U.S. dollars), regulation of fund transfers by foreign governments, U.S. and foreign export and import duties and tariffs, and political instability.